Recurrent Adult Soft Tissue Sarcoma Completed Phase 1 / 2 Trials for Imatinib (DB00619)

IndicationStatusPhase
DBCOND0028931 (Recurrent Adult Soft Tissue Sarcoma)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01281865Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue SarcomaTreatment